Oragenics Receives NYSE American Approval of Compliance Plan and Extension Through February 2028GlobeNewswire Nov 12, 2026, 9:00:00 PM
Oragenics Chief Medical Officer to Present at IPAC-RS 2026 Nasal Innovation ForumGlobeNewswire Sep 16, 2026, 12:30:00 PM
Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing UpdateGlobeNewswire Aug 28, 2026, 8:25:00 PM